Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pregabalin | Drug | |||
| Venlafaxine XR | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the efficacy of pregabalin and Venlafaxine XR in the treatment of generalized anxiety disorder. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | De Pinte | Belgium | ||||
| Pfizer Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21456104 | Derived | Kasper S, Herman B, Nivoli G, Van Ameringen M, Petralia A, Mandel FS, Baldinetti F, Bandelow B. Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. Int Clin Psychopharmacol. 2009 Mar;24(2):87-96. doi: 10.1097/yic.0b013e32831d7980. |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ghent |
| Belgium |
| Pfizer Investigational Site | Waregem | Belgium |
| Pfizer Investigational Site | Kelowna | British Columbia | Canada |
| Pfizer Investigational Site | Hamilton | Ontario | Canada |
| Pfizer Investigational Site | Ottawa | Ontario | Canada |
| Pfizer Investigational Site | Gatineau | Quebec | Canada |
| Pfizer Investigational Site | Saint-Jean-sur-Richelieu | Quebec | Canada |
| Pfizer Investigational Site | Angoulême | France |
| Pfizer Investigational Site | Arcachon | France |
| Pfizer Investigational Site | Bully-les-Mines | France |
| Pfizer Investigational Site | Cherbourg | France |
| Pfizer Investigational Site | Élancourt | France |
| Pfizer Investigational Site | Orvault | France |
| Pfizer Investigational Site | Rennes | France |
| Pfizer Investigational Site | Saint-André-de-Cubzac | France |
| Pfizer Investigational Site | Savigny-sur-Orge | France |
| Pfizer Investigational Site | Strasbourg | France |
| Pfizer Investigational Site | Versailles | France |
| Pfizer Investigational Site | Bray | County Wicklow | Ireland |
| Pfizer Investigational Site | Vicenza | Bassano DEL Grappa | Italy |
| Pfizer Investigational Site | Città di Castello | Perugia | Italy |
| Pfizer Investigational Site | Catania | Italy |
| Pfizer Investigational Site | Sassari | Italy |
| Pfizer Investigational Site | Wildervank | Provincie Groningen | Netherlands |
| Pfizer Investigational Site | Hoogvliet | Netherlands |
| Pfizer Investigational Site | Huizen | Netherlands |
| Pfizer Investigational Site | Losser | Netherlands |
| Pfizer Investigational Site | Musselkanaal | Netherlands |
| Pfizer Investigational Site | Oude Pekela | Netherlands |
| Pfizer Investigational Site | Vic | Barcelona | Spain |
| Pfizer Investigational Site | Alcalá de Henares | Madrid | Spain |
| Pfizer Investigational Site | Langreo | Principality of Asturias | Spain |
| Pfizer Investigational Site | Gandia | Valencia | Spain |
| Pfizer Investigational Site | Barcelona | Spain |
| Pfizer Investigational Site | Madrid | Spain |
| Pfizer Investigational Site | Salamanca | Spain |
| Pfizer Investigational Site | Zamora | Spain |
| Pfizer Investigational Site | Gothenburg | Sweden |
| Pfizer Investigational Site | Linköping | Sweden |
| Pfizer Investigational Site | Lund | Sweden |
| Pfizer Investigational Site | Malmö | Sweden |
| Pfizer Investigational Site | Stockholm | Sweden |
| Pfizer Investigational Site | Sundsvall | Sweden |
| Pfizer Investigational Site | Trollhättan | Sweden |
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided